We Serve

Clinical Diagnostics

Discover how our data-driven solutions have helped stakeholders in Precision Medicine drive growth and stay ahead of the curve

What we do

Select Capabilities

All Capabilities

Go-to-Market Strategy

It’s time to execute. Understanding your customers, competitors, channels, and messaging is just the first step. Going to market requires coordination and alignment across the organization, and an ivory-tower strategy won’t be enough - you need tactics.

Novel Technology Commercialization

Blazing a trail isn’t easy, but that’s not why you’re doing it. Navigating strategy for novel technologies and creating new, uncharted markets requires creativity, innovation, and experience. We’re here to help.

Pricing Strategy

Precise pricing is critical to realizing maximum adoption and market value. DeciBio takes a multi-pronged approach to triangulate optimal price points for your products and services.

Impact

Selected Work

Clinical Diagnostics

New Prenatal Opportunity Assessment

A multinational pharmaceutical and diagnostics company was interested in learning more about the U.S. market opportunity for their novel noninvasive prenatal test in development

Voice-of-Customer Research

Go-to-Market Strategy

Clinical Diagnostics

MRD Monitoring Market Assessment and Strategy

A diagnostics player wanted to determine with indications / use cases to target and develop a product road map

Biomarker and Diagnostics Strategy

Go-to-Market Strategy

Market Landscaping and Sizing

Clinical Diagnostics

Low-Throughput Molecular Diagnostic Testing Landscape Assessment

A leading diagnostic company wanted an assessment of the future market landscape for low-throughput (LT) molecular diagnostic (MDx) testing to develop a long-term platform strategy to address the future needs of this market

Voice-of-Customer Research

Competitive Analysis

Customer Segmentation

Featured Team

David Cavanaugh

Founding Partner

Andrew Aijian

Katie Maloney

Data & Platforms

Pharma Real-Word Data & Evidence Market Report, First Edition: 2025-2030

The first edition of this report provides a comprehensive overview of the global real-world data and evidence (RWD/E) market from 2025 to 2030. RWD has become increasingly central in life sciences decision-making, empowering organizations to generate insights that enhance research, clinical development, and commercial decision-making. The market is expanding as data types diversify, spanning electronic health records, claims, imaging, and omics, and as analytics become more advanced through AI and federated data approaches. Key players include data aggregators, generators (e.g., Guardant Health, Natera), enablers (e.g., COTA, Aetion), as well as players that span multiple functions (e.g., Tempus, Flatiron, NashBio).

Global In Vitro Diagnostics Market Report, First Edition: 2025-2030

DeciBio’s Global In Vitro Diagnostics Market Report, First Edition: 2025-2030, is an in-depth, data-driven resource designed to support strategic decision-making in the IVD space. This report provides a summary of the current IVD landscape, as well as a forward-looking perspective of the IVD market from 2025 to 2030. Content includes a rigorous assessment of industry market size, growth and key trends. In addition, we provide detailed segmentation by modality, therapeutic area, and geography.

Proteomics Tools Report: Research & Clinical Markets, First Edition: 2025-2030

The first edition of this report provides a comprehensive overview of the global proteomics tools market from 2025 to 2030. These tools are fundamental to life sciences, enabling the analysis of proteins, the functional endpoints of biological pathways. The landscape is highly dynamic, with a clear duality: established, first-generation tools (e.g., IHC, ELISAs, Western blot) remain critical in clinical trials and routine diagnostics, while a high-growth research segment is driven by innovative technologies like high-plex affinity platforms and spatial proteomics. The vendor landscape includes large corporations such as Thermo Fisher Scientific and Roche, as well as specialized innovators like Olink, SomaLogic, and Quantum-Si.

Analytical Instrument Utilization Report

This report provides a summary of historical (2019-2025) and expected (2025-2027) analytical instrument use across academic core laboratories in the U.S., Europe, and APAC.

Insights Blog

Precision Medicine is evolving at a rapid pace

Discover how we can help